Bristol-Myers Squibb Company
BMY
$46.55
$0.621.35%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.53% | -9.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.53% | -9.24% | |||
| Cost of Revenue | 11.20% | -6.04% | |||
| Gross Profit | 8.92% | -10.37% | |||
| SG&A Expenses | 6.96% | -14.63% | |||
| Depreciation & Amortization | 0.00% | -50.97% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.18% | -19.70% | |||
| Operating Income | 16.80% | 26.42% | |||
| Income Before Tax | -40.36% | 1,597.71% | |||
| Income Tax Expenses | -9.63% | 414.14% | |||
| Earnings from Continuing Operations | -46.71% | 3,139.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 66.67% | -50.00% | |||
| Net Income | -46.66% | 3,311.11% | |||
| EBIT | 16.80% | 26.42% | |||
| EBITDA | 12.40% | -2.09% | |||
| EPS Basic | -46.77% | 3,306.48% | |||
| Normalized Basic EPS | 14.34% | 50.01% | |||
| EPS Diluted | -46.67% | 3,280.28% | |||
| Normalized Diluted EPS | 14.68% | 49.93% | |||
| Average Basic Shares Outstanding | 0.20% | 0.10% | |||
| Average Diluted Shares Outstanding | -0.10% | 0.15% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.88% | -0.97% | |||